Insider · CIK 0001690460

Dorsch Marion

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001690460

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-02-22	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+7,578 sh	$37.11	+$281K	22,828
2021-02-22	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−7,578 sh	—	—	40,422
2021-02-22	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−7,578 sh	$100.00	−$758K	15,250
2020-12-14	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,600 sh	—	—	48,000
2020-12-14	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−4,600 sh	$119.00	−$547K	15,250
2020-12-14	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,600 sh	$37.11	+$171K	19,850
2020-10-06	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,600 sh	—	—	52,600
2020-10-06	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,600 sh	$37.11	+$171K	19,850
2020-10-06	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−4,600 sh	$99.00	−$455K	15,250
2020-09-23	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,600 sh	$37.11	+$171K	19,850
2020-09-23	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,600 sh	—	—	57,200
2020-09-23	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−4,600 sh	$89.00	−$409K	15,250
2020-06-19	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,600 sh	$37.11	+$171K	19,850
2020-06-19	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,600 sh	—	—	61,800
2020-06-19	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−4,600 sh	$79.00	−$363K	15,250
2020-03-23	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−199 sh	$55.14	−$11K	16,265
2020-03-23	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−774 sh	$51.52	−$39.9K	15,250
2020-03-23	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−241 sh	$53.43	−$12.9K	16,024
2020-03-09	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−536 sh	$51.99	−$27.9K	16,464
2020-03-01	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+20K sh	—	—	20,000
2020-03-01	Blueprint Medicines CorpA Award	Chief Scientific Officer	AAward	+10K sh	—	—	17,000
2019-12-19	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,600 sh	—	—	66,400
2019-12-19	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,600 sh	$37.11	+$171K	4,600
2019-12-19	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−4,600 sh	$79.00	−$363K	0
2019-06-17	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−4,600 sh	$99.00	−$455K	0
2019-06-17	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,600 sh	$37.11	+$171K	4,600
2019-06-17	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,600 sh	—	—	71,000
2019-03-04	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−800 sh	$83.16	−$66.5K	107
2019-03-04	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,300 sh	$37.11	+$85.4K	2,300
2019-03-04	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−295 sh	$87.73	−$25.9K	2,005
2019-03-04	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−498 sh	$85.64	−$42.6K	1,507
2019-03-04	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−600 sh	$84.72	−$50.8K	907
2019-03-04	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−107 sh	$82.56	−$8,833.92	0
2019-03-04	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,300 sh	—	—	75,600
2019-03-01	Blueprint Medicines CorpRestricted Stock UnitsA Award	Chief Scientific Officer	AAward	+7,000 sh	—	—	7,000
2019-03-01	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+26K sh	—	—	26,000
2018-09-17	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−300 sh	$73.05	−$21.9K	2,000
2018-09-17	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,300 sh	—	—	116,900
2018-09-17	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−1,700 sh	$70.00	−$119K	0
2018-09-17	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,300 sh	$37.11	+$85.4K	2,300
2018-09-17	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−300 sh	$70.59	−$21.2K	1,700
2018-03-15	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,300 sh	—	—	119,200
2018-03-15	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,300 sh	$37.11	+$85.4K	2,300
2018-03-15	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−2,300 sh	$100.07	−$230K	0
2018-02-16	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+39K sh	—	—	121,500
2017-11-22	Blueprint Medicines CorpM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+9,166 sh	$37.11	+$340K	9,166
2017-11-22	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−9,166 sh	—	—	82,500
2017-11-22	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−9,166 sh	$70.00	−$642K	0
2017-11-21	Blueprint Medicines CorpStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−18.3K sh	—	—	91,666
2017-11-21	Blueprint Medicines CorpS Sale	Chief Scientific Officer	SSale	−4,750 sh	$65.81	−$313K	11,983

Recent filings

Accepted (ET)
Feb 244
Dorsch Marion0001179110-21-002211
SEC(opens sec.gov)
Dec 164
Dorsch Marion0001179110-20-011988
SEC(opens sec.gov)
Oct 84
Dorsch Marion0001179110-20-010351
SEC(opens sec.gov)
Sep 254
Dorsch Marion0001179110-20-009960
SEC(opens sec.gov)
Jun 234
Dorsch Marion0001179110-20-007715
SEC(opens sec.gov)
Mar 254
Dorsch Marion0001179110-20-004115
SEC(opens sec.gov)
Mar 114
Dorsch Marion0001179110-20-003475
SEC(opens sec.gov)
Mar 34
Dorsch Marion0001179110-20-002955
SEC(opens sec.gov)

Companies

Blueprint Medicines CorpChief Scientific Officer

Address

C/O BLUEPRINT MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200

CAMBRIDGE, MA, 02139